Meta-analysis when only the median survival times are known: a comparison with individual patient data results.
about
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationBotulinum toxin type B for cervical dystoniaAntiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisSipuleucel-T for metastatic castration-resistant prostate cancerChemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancerChemotherapy for metastatic and recurrent cervical cancerSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseContinuation and maintenance treatments for depression in older peopleNitrous Oxide for ColonoscopyAntiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseNeuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisSipuleucel-T for metastatic castration-resistant prostate cancerLet-7 microRNA-binding-site polymorphism in the 3'UTR of KRAS and colorectal cancer outcome: a systematic review and meta-analysisPrognostic role of survivin in bladder cancer: a systematic review and meta-analysisThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationIndividual participant data meta-analyses compared with meta-analyses based on aggregate data.Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial.Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancerDepression and risk of mortality in individuals with diabetes: a meta-analysis and systematic reviewHospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis.Prognostic role of ERCC1 in advanced non-small-cell lung cancer: a systematic review and meta-analysis.A comparison of long-term outcomes of portal versus systemic venous drainage in pancreatic transplantation: a systematic review and meta-analysis.Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.Continuation and maintenance treatments for depression in older people.Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA ApprovalA meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.Association between mesothelin expression and survival outcomes in patients with triple-negative breast cancer: a protocol for a systematic review.Prognostic value of microRNAs in osteosarcoma: A meta-analysis.Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis.Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases.Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis.Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival.
P2860
Q21092360-968EC089-7003-4FC6-8B0C-719202362A9AQ24185766-BF9695BE-EB4C-49D4-B577-9F4658890440Q24186663-B9E1F5FD-3969-487B-AC9A-C3B4DCEC639DQ24186731-111516E7-8FB9-4566-B0BA-FAD91EC6D715Q24194621-301E45CA-CA60-46D7-8C65-3D0AB2DEB201Q24198084-0DC6E19A-C367-4A3D-A5B8-098A747610EBQ24200518-B3677CC2-AEF8-4C40-8FC2-903C8BB2931BQ24202971-E5D60B19-A742-4BD9-8095-CD74DD697B5FQ24234985-5DAF2A5A-3309-425B-AF35-B89ECB1FFD70Q24235637-2B99740F-03F8-43A0-833C-DECDF0BFFC20Q24243664-1F2C0CE8-F7C7-49B4-BB04-35979684ABC2Q24644585-154A938F-6C59-447A-A447-A43E7B6F4B8BQ26471816-45057AF2-1BD0-4DA8-A256-688F00EDFE94Q26827474-0AE5BD81-8423-4D43-95E7-E372C6E73B1CQ27028122-02FD78DE-F9E3-4BAB-8EC0-1C9383E18433Q27860581-641CFFA9-DCAC-418A-A03A-114B328E50E2Q31126782-434E96D7-202A-4F75-B228-2BA999A757E9Q33433507-048AA2B0-BA35-4844-9659-6F0C7BA30488Q33600403-C3E97A49-F222-4757-9D92-3CFEDBA87435Q34148380-A0844FAB-5B69-4912-97A1-D6D38923AFB6Q34216253-0C7C9260-3289-418F-B120-4507912E0A28Q34588907-46B38C50-A1CE-43B4-B239-BBE98DB79B17Q35051950-3DA421F7-34BA-4A13-AF3F-592B97A9B701Q35510634-F2114E32-AA48-4222-90B7-F79F1F470590Q35690568-18A4A9B9-E795-4EC7-82C8-50CD4B840E98Q35931634-E88DC94F-904F-42F1-A3F5-87F8F2FD581CQ36127393-C71F7B72-B411-4826-A95A-69E11537CD36Q36534696-58B061F3-61AF-453D-8298-E305D1A75A00Q36871001-B2AA69A9-0992-40F8-84CE-B3AA19248A12Q36934253-D088E0C6-3C2B-4625-B467-7CFEB0407EFCQ37170197-FE4F9ED2-121B-4254-B005-D2551D5A8CDFQ37702789-0EEC70E3-72DC-4F89-8C77-7539DBB460AEQ37869402-041535C4-D46A-418E-A782-121BA79340B5Q37977308-8F681A98-E5EF-4DF8-A039-9753CAF27410Q38062459-0AFECEBF-8A8B-4366-8C61-0353962F80E5Q38074263-6A6DD343-A427-4AFC-9562-560C01AF0B43Q38092435-86A67EE8-3FFE-4748-99D7-D45FAC35F522Q38165914-90DB6A3D-39FE-4098-AEA3-0393D642834AQ38220155-67C8CAA3-1F3B-4422-B3C6-20B85CA03D9BQ38480274-C2B556B8-D49E-4B7B-A3A5-2D5215982827
P2860
Meta-analysis when only the median survival times are known: a comparison with individual patient data results.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Meta-analysis when only the me ...... dividual patient data results.
@ast
Meta-analysis when only the me ...... dividual patient data results.
@en
type
label
Meta-analysis when only the me ...... dividual patient data results.
@ast
Meta-analysis when only the me ...... dividual patient data results.
@en
prefLabel
Meta-analysis when only the me ...... dividual patient data results.
@ast
Meta-analysis when only the me ...... dividual patient data results.
@en
P2093
P2860
P1476
Meta-analysis when only the me ...... dividual patient data results.
@en
P2093
Lesley Stewart
Nathalie Syz
Pascal Piedbois
Sarah Burdett
P2860
P304
P356
10.1017/S0266462305050154
P577
2005-01-01T00:00:00Z